Sample Preparation, Consumables, LC columns
IndustriesClinical Research
ManufacturerMerck
Significance of the Topic
High-throughput bioanalysis is critical for advancing drug development, toxicology studies, and clinical research by enabling rapid quantitation of target compounds in biological matrices. However, minimal sample preparation and expedited chromatographic separations often compromise data quality due to residual matrix interferences such as phospholipids. Integrating innovative chromatographic materials with selective sample cleanup is essential to achieve both speed and accuracy in bioanalytical workflows.
Objectives and Study Overview
This study evaluates the performance of fused-core particle columns under reversed-phase (RP) and hydrophilic interaction/aqueous normal phase (HILIC/ANP) conditions for separating morphine and morphine 3-β glucuronide in spiked rat plasma. Key goals include:
- Achieving baseline separation of both analytes in under one minute.
- Assessing the impact of endogenous phospholipid matrix on analysis time and reproducibility.
- Comparing traditional protein precipitation with a novel HybridSPE-PPT cleanup for matrix removal.
Methodology and Instrumentation
Sample Preparation:
- Protein Precipitation (PPT): Plasma (100 µL) mixed with 300 µL of 1% formic acid in acetonitrile, vortexed, centrifuged, evaporated, and reconstituted (10:90 acetonitrile:water).
- HybridSPE-PPT Cleanup: Plasma (100 µL) loaded on zirconia-coated 96-well plate, treated with 300 µL of 1% formic acid acetonitrile, agitated, and filtered under vacuum; filtrate analyzed directly or reconstituted for RP.
Chromatography and Detection:
- Columns: Ascentis Express C18 and Ascentis Express HILIC, fused-core particles (5 cm×2.1 mm, 2.7 µm).
- Mobile Phases: Ammonium formate buffers with varying organic content (RP: pH 3.6 A/B gradient; HILIC: 90:10 acetonitrile:water, pH 4.2, isocratic).
- Flow Rate & Temperature: 0.6 mL/min, 50 °C.
- Detection: Electrospray ionization positive mode, accurate-mass time-of-flight MS (Agilent 1200SL Rapid Resolution & Agilent 6210 TOF LC/MS).
Main Results and Discussion
Under RP conditions, morphine and its glucuronide eluted within one minute, but complete elution of phospholipids required extended gradient washing, lengthening the cycle to 10 minutes. HILIC/ANP also delivered sub-minute analyte separation yet needed over six minutes to clear matrix components due to strong retention of phospholipid head groups on the bare silica phase.
Implementing HybridSPE-PPT effectively removed phospholipid interferences via selective Lewis acid/base interactions with zirconia-coated particles. This cleanup enabled both RP and HILIC/ANP separations to operate isocratically without additional gradient steps, reducing total analysis cycles to under one minute while maintaining chromatographic efficiency and reproducibility.
Benefits and Practical Applications
- Substantially increased sample throughput by eliminating lengthy column wash steps.
- Simplified workflow with no additional instrumentation or complex SPE method development.
- Enhanced data quality through thorough removal of phospholipid matrix, improving sensitivity and quantitation reliability.
- Flexibility to apply either RP or HILIC/ANP modes based on analyte polarity.
Future Trends and Opportunities
- Development of novel hybrid stationary phases combining high selectivity and robustness for ultra-fast separations.
- Integration of automated microflow and nano-LC systems for reduced solvent consumption and higher resolution.
- Advancements in online SPE and microextraction techniques for seamless sample preparation and analysis.
- Application of machine learning to optimize method parameters for diverse bioanalytical targets.
Conclusion
The combination of fused-core particle chromatography and HybridSPE-PPT sample cleanup offers a powerful strategy for truly high-throughput bioanalysis. By addressing phospholipid matrix interferences at the sample prep stage, both RP and HILIC/ANP methods achieve rapid, efficient, and reproducible quantitation of analytes in plasma, meeting the demands of modern bioanalytical laboratories.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.